
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM, THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA), AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA, IN ANY MEMBER STATE OF THE EEA OR IN ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.
This announcement is not an offer to sell, or a solicitation of an offer to acquire, securities in the United States or in any other jurisdiction in which the same would be unlawful. Neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.
Legal Entity Identifier: 5493007C3I0O5PJKR078
28 May 2025
JPMorgan Global Growth & Income plc
Combination with Henderson International Income Trust plc
Results of the Scheme and Issue of Scheme Shares
Results of the Scheme and Issue of Scheme Shares
The Board of JPMorgan Global Growth & Income plc (the "Company" or "JGGI") is pleased to announce that the Company will acquire substantially all of the net assets from Henderson International Income Trust plc ("HINT") in exchange for the issue of 64,261,713 new shares in the capital of JGGI ("Scheme Shares") in connection with the voluntary winding up of HINT pursuant to a scheme of reconstruction under section 110 of the Insolvency Act 1986 (the "Scheme") following the passing today of the resolution proposed at the Second General Meeting of HINT.
JGGI ordinary shares
The number of Scheme Shares to be issued to Eligible HINT Shareholders and to the liquidators of HINT for sale in the market for the benefit of Excluded HINT Shareholders was calculated based on a FAV per JGGI share of 534.660514 pence and a FAV per HINT share of 175.317407 pence, producing a conversion ratio of approximately 0.327904 JGGI shares per HINT share, each calculated in accordance with the Scheme.
As set out in the shareholder circular published by the Company on 17 April 2025 (the "Circular"), fractions of Scheme Shares arising as a result of the conversion ratio will not be issued under the Scheme and entitlements to such Scheme Shares will be rounded down to the nearest whole number.
Admission
Applications have been made by the Company for the Scheme Shares to be admitted to listing on the Official List of the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange (together, "Admission"). It is expected that Admission will take place at 8.00am on 29 May 2025.
Following the issue of the Scheme Shares noted above, the Company's share capital will comprise 581,839,021 ordinary shares (excluding treasury shares), with each ordinary share entitled to one voting right per ordinary share such that, following Admission, the total voting rights of the Company will be 581,839,021. The Company does not hold any shares held in treasury.
The figure of 581,839,021 may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in voting rights, or a change to their interest in the Company, under the Disclosure, Guidance and Transparency Rules.
Capitalised terms used but not defined in this announcement will have the same meaning as set out in the Circular.
For further information:
JPMorgan Global Growth & Income plc James Macpherson
| Contact via Company Secretary |
JPMorgan Funds Limited Simon Crinage Will Talkington
| +44 (0) 20 7742 4000 |
JPMorgan Funds Limited (Company Secretary) Emma Lamb
| +44 (0) 20 7742 4000 |
Winterflood Securities Limited Neil Langford Haris Khawaja
| +44 (0) 20 3100 0000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.